Some providers featured on this site may compensate us. This may affect the order and placement of listings but does not influence our editorial ratings or reviews.
Treatments Hub

Verified prices

All verified prices
Wellness8 min read

GLP-1 Weight Loss for Women: What You Need to Know in 2026

How GLP-1 medications like semaglutide and tirzepatide work for women's weight loss - hormonal considerations, results, pregnancy safety, and finding the right provider.

Updated September 15, 2026

Medically reviewed on

How we review

Our top 2 picks

Our two recommended GLP-1 providers, shown with the same verified pricing and ratings as our full comparison.

Our Top Pick
1
embody logo

Exceptional

9.8out of 10

Compounded GLP-1 from $49/month; not FDA-approved, free expedited delivery

Free expedited deliveryNo hidden fees
  • Compounded semaglutide ($49/mo) and tirzepatide ($99/mo) as shown on the homepage, Nov 16, 2026; not FDA-approved
  • Online intake, then a prescriber review by OpenLoop Health, a network of US-licensed doctors
  • Free expedited delivery (embody's words); the Terms do not guarantee a delivery timeline
  • No insurance required, no clinic visits; cancel at least 72 hours before the next billing date

from $49/month

Doctor-prescribed compounded GLP-1 treatment, not FDA-approved: semaglutide shown at $49/month and tirzepatide at $99/month on embody's homepage (Nov 16, 2026), no insurance required.

Read full embody review
2
altRx logo

Excellent

9.4out of 10

Most Comprehensive GLP-1 Medication Access

Transparent pricingNo insurance required
  • Compounded GLP-1 from $89/mo, GLP-1 + GIP from $149/mo
  • Brand-name options too: Zepbound and Wegovy
  • Clinician-guided - physician, PA, or nurse practitioner
  • Free shipping (about 5-7 days)

from $89/month

Affordable GLP-1 program from $89/month - compounded semaglutide and tirzepatide plus brand-name options - with clinician-guided, self-pay care and no insurance required.

Read full altRx review

How Hormones Affect the Response

Women's hormonal fluctuations can influence how GLP-1 medications work. Some women report that side effects like nausea are slightly worse during certain phases of their menstrual cycle.

Hormonal changes during perimenopause and menopause can also affect weight loss patterns. The good news: GLP-1 medications work with your hormones, not against them.

They mimic natural satiety hormones that help regulate appetite regardless of hormonal status.

Pregnancy and Fertility Considerations

GLP-1 medications should be stopped at least 2 months before trying to conceive. They are not safe during pregnancy or breastfeeding.

Interestingly, some women on GLP-1 medications have reported unexpected pregnancies - possibly because weight loss can improve fertility, especially in women with PCOS or obesity-related hormonal imbalances. If you are of childbearing age, discuss contraception with your provider.

See our eligibility guide for full safety information.

Weight Loss Results for Women

Clinical trial data shows women achieve results comparable to men. In the STEP trials, women on semaglutide lost an average of 15-17% of body weight.

In the SURMOUNT trials, tirzepatide results were even higher. Individual results vary based on starting weight, metabolic health, medication adherence, and lifestyle factors.

Read our semaglutide results timeline for realistic expectations.

Shop GLP-1 plans by product

The lowest published plans - cheapest first, conditions under each price.

What To Know Before Starting GLP-1 Treatment

Before starting GLP-1 treatment, it's important to understand a few key things. These medications require a prescription from a licensed clinician and aren't suitable for everyone. Some people may experience side effects, especially during the first few weeks as the body adjusts.

GLP-1s also tend to work best when combined with basic lifestyle habits like balanced nutrition and regular physical activity.

That's why choosing a provider that offers proper medical screening and ongoing follow-up support is essential for both safety and long-term success.

Woman preparing GLP-1 weight loss injection

Managing Side Effects

Women report the same primary side effects as men: nausea, constipation, diarrhea, and reduced appetite. These are most common during dose increases and typically improve within 2-4 weeks.

Strategies that help: eating small, protein-rich meals; staying hydrated; avoiding greasy foods; and ginger tea for nausea. Read our full side effects management guide and nutrition guide.

Preserving Muscle While Losing Weight

Women naturally have less muscle mass than men, making muscle preservation during weight loss especially important. Adequate protein intake (80-120g daily) and resistance training 2-3 times per week are essential.

This isn't about becoming a bodybuilder - it's about maintaining the metabolic rate and physical function that support long-term weight maintenance. See our exercise guide.

Finding the Right Provider

The best provider for you depends on your goals, budget, and how much support you want. Some women prefer comprehensive programs with coaching (like Noom), while others prefer streamlined medication access (like altRx or ro). Take our matching quiz for a personalized recommendation, or compare all providers side by side.

Ready to compare weight loss providers?

See how top providers stack up on pricing, medical support, and treatment options.

Medical disclaimer

This page is general information about GLP-1 weight-loss medications such as semaglutide and tirzepatide, published to help you compare services. It is not medical advice, it does not create a doctor-patient relationship, and it is not a substitute for a consultation with a licensed clinician who knows your history. Treatments Hub is not a medical provider, pharmacy or clinic and does not prescribe, sell or dispense medication. Do not start, stop or change any treatment because of something you read here, and do not delay seeking care; in an emergency call 911.

Semaglutide and tirzepatide carry an FDA boxed warning about thyroid C-cell tumours seen in rodents and are not for anyone with a personal or family history of medullary thyroid carcinoma or MEN 2, nor for use in pregnancy. Compounded versions sold by telehealth providers are prepared by state-licensed pharmacies and are not FDA-approved products. Where a review or post on this page mentions weight lost, that is one person's result and is not typical; results vary widely.

Medical and scientific statements on this site are checked against the sources linked on the page by our medical content reviewer, who does not choose providers or set prices. Prices, plans and customer reviews are each provider's published figures and customers' own words on the dates stated. We may earn a commission from provider links. The full medical and advertising disclaimer explains all of this in detail.

Sources & medical references

Treatment facts on this page are grounded in regulatory guidance and peer-reviewed research. Pricing and plan details come from each provider's published information. This content is for information only and is not medical advice - always consult a licensed clinician before starting treatment.

  1. 1.Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1 trial) - New England Journal of Medicine, 2021
  2. 2.Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1 trial) - New England Journal of Medicine, 2022
  3. 3.FDA Approves New Drug Treatment for Chronic Weight Management (semaglutide / Wegovy) - U.S. Food & Drug Administration, 2021
  4. 4.FDA Approves New Medication for Chronic Weight Management (tirzepatide / Zepbound) - U.S. Food & Drug Administration, 2023
  5. 5.FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss - U.S. Food & Drug Administration
  6. 6.Human Drug Compounding (503A pharmacy standards) - U.S. Food & Drug Administration
  7. 7.Semaglutide Injection - drug information - MedlinePlus, U.S. National Library of Medicine (NIH)